Nine cases of reactions have been reported in New Zealand since 2023 ranging in seriousness from rash, shortness of breath, ...

The Air Force has turned the emergency room at its Wilford Hall Ambulatory Surgical Center into an urgent care. It says ...

Canada for adults and children (>30 kg) living with severe allergic reactions ALK- Abelló A/S, which licenses the rights to market neffy in Canada, expects availability in the summer of 2026 SAN DIEGO ...

Venomous Asian needle ants are quietly spreading across the U.S. Have they reached Alabama? Here's what to know about the ...

Prefilled syringes (PFS) preferred on pharmacy benefit; vials preferred on medical benefit RALEIGH, N.C., April 20, 2026 /PRNewswire/ -- Accord BioPharma, the U.S. specialty division of Intas ...

ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced that Health Canada has approved neffy® 2 mg for the emergency treatment of allergic reactions (anaphylaxis) due to insect stings or bites, ...

TORONTO - Health Canada has approved the first needle-free epinephrine treatment for severe allergic reactions: a nasal spray ...

Danish allergy immunotherapy specialist ALK Abello today announced that Health Canada has approved Neffy 2mg adrenaline ...

TORONTO, April 15, 2026 /CNW/ – ALK-Abello Pharmaceuticals Inc. Canada (ALK Canada) today announced that Health Canada has approved neffy® 2 mg for the emergency treatment of allergic ...

In the last 10 years, several advancements in peanut allergy management have emerged, including Palforzia, omalizumab and ...

There are several gluten-related disorders (GRDs), including celiac disease, non-celiac gluten sensitivity (NCGS), and wheat allergy. Celiac disease is the most severe GRD. Without treatment, it can ...